技术与方法 |
|
|
|
|
基于TCID50检测AAV9载体制品感染性滴度的方法 |
王聪1,2,李秀2,牛苗2,戴阳光2,董哲岳2,董小岩2,余双庆2,*(),杨怡姝1,*() |
1 北京工业大学 北京 100124 2 北京五加和基因科技有限公司 北京 102629 |
|
Research on AAV9 Infectious Titer Detection Method Based on TCID50 |
WANG Cong1,2,LI Xiu2,NIU Miao2,DAI Yang-guang2,DONG Zhe-yue2,DONG Xiao-yan2,YU Shuang-qing2,*(),YANG Yi-shu1,*() |
1 Beijing University of Technology, Beijing 100124,China 2 Beijing FivePlus Gene Technology Co., Ltd., Beijing 102629, China |
引用本文:
王聪,李秀,牛苗,戴阳光,董哲岳,董小岩,余双庆,杨怡姝. 基于TCID50检测AAV9载体制品感染性滴度的方法[J]. 中国生物工程杂志, 2021, 41(10): 28-32.
WANG Cong,LI Xiu,NIU Miao,DAI Yang-guang,DONG Zhe-yue,DONG Xiao-yan,YU Shuang-qing,YANG Yi-shu. Research on AAV9 Infectious Titer Detection Method Based on TCID50. China Biotechnology, 2021, 41(10): 28-32.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2106006
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I10/28
|
[1] |
Wang D, Tai P W L, Gao G P. Adeno-associated virus vector as a platform for gene therapy delivery. Nature Reviews Drug Discovery, 2019, 18(5): 358-378.
doi: 10.1038/s41573-019-0012-9
pmid: 30710128
|
[2] |
张岩松, 陈丽娇, 张婷, 等. 基因治疗的研究进展. 中国细胞生物学学报, 2020, 42(10): 1858-1869.
|
|
Zhang Y S, Chen L J, Zhang T, et al. Research progresses of gene therapy. Chinese Journal of Cell Biology, 2020, 42(10): 1858-1869.
|
[3] |
Goncalves M A. Adeno-associated virus: from defective virus to effective vector. Virology Journal, 2005, 2(1): 43.
doi: 10.1186/1743-422X-2-43
|
[4] |
Schnödt M, Büning H. Improving the quality of adeno-associated viral vector preparations: the challenge of product-related impurities. Human Gene Therapy Methods, 2017, 28(3): 101-108.
doi: 10.1089/hgtb.2016.188
|
[5] |
曹晖, 王宏伟, 谭淑萍, 等. 一种重组腺相关病毒载体感染滴度的测定方法: 中国, CN101386891A. 2009-03-18[2021-06-01].
|
|
Cao H, Wang H W, Tan S P, et al. A method for determining the infection titer of recombinant adeno-associated virus vectors: China, CN101386891A. 2009-03-18[2021-06-01].
|
[6] |
伍志坚, 吴小兵, 曹晖, 等. 一种高效的重组腺伴随病毒载体生产系统. 中国科学(C辑: 生命科学), 2001, 31(5): 423-430.
|
|
Wu Z J, Wu X B, Cao H, et al. An efficient recombinant adeno-associated virus vector production system. Scientia Sinica(Vitae), 2001, 31(5): 423-430.
|
[7] |
伍志坚, 吴小兵, 侯云德. 具有AAV载体包装功能的重组HSV的产生. 科学通报, 1999, 44(5): 506-509.
|
|
Wu Z J, Wu X B, Hou Y D. Production of recombinant HSV with AAV vector packaging function. Chinese Science Bulletin, 1999, 44(5): 506-509.
|
[8] |
Aurnhammer C, Haase M, Muether N, et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Human Gene Therapy Methods, 2012, 23(1): 18-28.
doi: 10.1089/hgtb.2011.034
|
[9] |
张静, 李伟华, 陈顺英, 等. 用蚀斑法进行麻疹疫苗的病毒滴定. 微生物学免疫学进展, 1999(1): 37-40.
|
|
Zhang J, Li W H, Chen S Y, et al. Plaque assay for the titration of measles vaccine. Progress in Microbiology and Immunology, 1999(1): 37-40.
|
[10] |
Zen Z, Espinoza Y, Bleu T, et al. Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious events. Human Gene Therapy, 2004, 15(7): 709-715.
doi: 10.1089/1043034041361262
|
[11] |
Zolotukhin S, Byrne B J, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy, 1999, 6(6): 973-985.
pmid: 10455399
|
[12] |
Zincarelli C, Soltys S, Rengo G, et al. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Molecular Therapy, 2008, 16(6): 1073-1080.
doi: 10.1038/mt.2008.76
pmid: 18414476
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|